Oslo, Norway, 12 August 2021
Vistin Pharma ASA will release its second quarter 2021 results on
Thursday 19(th) of August 2021. Vistin Pharma will host a conference call for
all shareholders and interested parties on Thursday 19(th) of August at 08:30
CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The second quarter conference call will be available via web and audio through
the following access points:
Telephone conference:
Confirmation Code: 7925407
International Dial-In: +44 (0) 203 0095709
Norway, Oslo: +47 21033922
United States, New York: +1 6467871226
Webcast:
https://edge.media-server.com/mmc/p/ejs5nvy8
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com (mailto:alexander.karlsen@vistin.com)
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.